Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Plasma Cell-Free DNA (cfDNA) as a Predictive and Prognostic Marker in Patients With Metastatic Breast CancerBreast Cancer Res 2019 Dec 19;[EPub Ahead of Print], D Fernandez-Garcia, A Hills, K Page, RK Hastings, B Toghill, KS Goddard, C Ion, O Ogle, AR Boydell, K Gleason, M Rutherford, A Lim, DS Guttery, RC Coombes, JA Shaw
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.